NCT06787365

Brief Summary

A number of risk factors that may be associated with endometriosis in adolescents (medical history and symptoms) are reported in the literature, but no overall estimate of disease risk has been developed. Providing a tool for assessing risk factors associated with endometriosis in adolescents by estimating disease risk could aid the clinician in diagnosis and reduce diagnostic delay

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

January 22, 2025

Status Verified

October 1, 2024

Enrollment Period

28 days

First QC Date

December 3, 2024

Last Update Submit

January 15, 2025

Conditions

Keywords

EndometriosisGynaecologyQuestionnaireRisk factorsPainful symptoms

Outcome Measures

Primary Outcomes (1)

  • Predictive model of endometriosis onset risk

    Predictive model of the occurrence of endometriosis based on the risk factors currently recognised in the literature (anamnestic data) and the results of a questionnaire consists of 28 multiple-choice questions, concerning symptoms experienced in adolescence

    During the first visit after enrollment

Study Arms (2)

Study group

Patients with endometriosis

Control group

Patients without endometriosis

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with and without a diagnosis of endometriosis

You may qualify if:

  • Women of childbearing age between 20 and 50 years
  • Acquisition of informed consent for participation in the study and processing of personal data

You may not qualify if:

  • \- Women suffering from other conditions responsible for pelvic pain (uterine fibromatosis, current or previous pelvic inflammatory disease, ovarian cysts of a non-endometriotic nature, irritable bowel syndrome, inflammatory bowel disease, interstitial cystitis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

Location

Azienda Ospedaliero-Universitaria Senese

Siena, Siena, 53100, Italy

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Simona Del Forno, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Simona Del Forno, MD

CONTACT

Roberto Palermo, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

January 22, 2025

Study Start

February 1, 2025

Primary Completion

March 1, 2025

Study Completion

April 1, 2025

Last Updated

January 22, 2025

Record last verified: 2024-10

Locations